Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB	Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, multidrug-resistant tuberculosis, mycobacterial infectious disease, tuberculosis	Active, not recruiting	Phase 2	2026-07-08		NCT03828201

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boston University	96
Harvard Medical School (HMS and HSDM)	37
National Institute of Allergy and Infectious Diseases (NIAID)	402
National Lung Hospital, Vietnam	2
Novartis Pharmaceuticals	432
Otsuka Pharmaceutical Co., Ltd.	22
Pfizer	431
TB-HIV Innovations & Clinical Research Foundation Corp, Philippines	1
University of California, San Francisco	637
University of Colorado, Denver	475

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Lung Hospital, Hanoi Lung Hospital	Hanoi	Vietnam	1
TB-HIV Innovations & Clinical Research Foundation Corp	Silang	Philippines	1